Kliogest

Norethisterone acetate and estradiol, the active ingredients in Kliogest, are a combined estrogen‑progestogen presented as an unspecified tablet for oral use. It prevents pregnancy in women of reproductive age. GNH USA supplies Kliogest as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kliogest is a combined estrogen‑progestogen oral contraceptive that acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy. - Contraception: provides reliable prevention of pregnancy when taken as directed. - Menstrual cycle regulation: helps establish a predictable monthly bleeding pattern. - Dysmenorrhea management: reduces menstrual pain and heavy bleeding associated with the cycle.

Kliogest may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset, often resolves with continued use. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding between periods. - Mood changes: irritability or mild depressive symptoms. - Weight fluctuation: slight increase or decrease in body weight.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Hypertension: sudden increase in blood pressure. - Liver dysfunction: jaundice or abnormal liver enzymes. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Visual disturbances: sudden loss of vision or eye pain. - Cardiovascular events: stroke or myocardial infarction.

Before prescribing Kliogest, clinicians should evaluate individual risk factors and counsel patients on safe use. - Contraindications: avoid in women with known thromboembolic disorders, active liver disease, or hormone‑dependent cancers. - Smoking: do not use in patients over 35 who smoke regularly. - Cardiovascular risk: assess history of hypertension, diabetes, or hyperlipidaemia. - Medication review: check for drugs that may increase clotting risk. - Pregnancy testing: confirm non‑pregnant status before initiation. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Kliogest can interact with several medicines that alter hormone metabolism or increase clotting risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect and increase bleeding. - Certain antiretrovirals (e.g., protease inhibitors): can reduce contraceptive efficacy. - St. John’s wort: induces hepatic enzymes, lowering hormone levels.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., carbamazepine, phenytoin): may decrease hormone concentrations. - Antibiotics (e.g., rifampicin): may modestly reduce effectiveness. - Herbal supplements (e.g., ginseng): could affect hormone metabolism.